Advanced Head And Neck Cancer clinical trials

Explore recruiting advanced head and neck cancer clinical trials.

Recruiting advanced head and neck cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Head And Neck Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NRG-HN009: RANDOMIZED PHASE II/III TRIAL OF RADIATION WITH CISPLATIN AT 100 MG/M2 EVERY THREE WEEKS VERSUS RADIATION WITH WEEKLY CISPLATIN AT 40 MG/M2 FOR PATIENTS WITH LOCOREGIONALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN).

Ireland

Phase II and Phase III (Integrated) EU CTIS Study details

A study to test BI 765179 alone and in combination with ezabenlimab in patients with advanced cancer (solid tumors) and BI 765179 in combination with pembrolizumab in patients with advanced head and neck cancer

Italy, Netherlands, Belgium, Spain, Czechia, France +1 more

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

EORTC 2120-HNCG: Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck squamous cell carcinoma: a randomized phase II study (Ravina)

Italy, Slovenia, Germany, Netherlands, Belgium, Norway +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Patient reported outcomes in term of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced head and neck cancer patients treated with definitive chemo-radiotherapy

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advanced Head And Neck Cancer trials by city

Advanced Head And Neck Cancer in Toronto Advanced Head And Neck Cancer in Vancouver Advanced Head And Neck Cancer in Montreal Advanced Head And Neck Cancer in Calgary Advanced Head And Neck Cancer in Edmonton Advanced Head And Neck Cancer in Ottawa Advanced Head And Neck Cancer in Winnipeg Advanced Head And Neck Cancer in Quebec City Advanced Head And Neck Cancer in Hamilton Advanced Head And Neck Cancer in Kitchener Advanced Head And Neck Cancer in London Advanced Head And Neck Cancer in Halifax Advanced Head And Neck Cancer in New York Advanced Head And Neck Cancer in Los Angeles Advanced Head And Neck Cancer in Chicago Advanced Head And Neck Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease